Amdocs (NASDAQ:DOX – Get Free Report) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 6.859-7.116 for the period, compared to the consensus estimate of 6.970. The company issued revenue guidance of $4.4 billion-$4.6 billion, compared to the consensus revenue estimate of $4.5 billion. Amdocs also updated its Q2 2025 guidance to 1.670-1.730 EPS.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on the stock. Oppenheimer lifted their price target on shares of Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. StockNews.com cut shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, January 14th. Finally, Barclays decreased their target price on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a research note on Thursday, November 14th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $101.20.
Check Out Our Latest Stock Analysis on DOX
Amdocs Trading Down 0.6 %
Amdocs (NASDAQ:DOX – Get Free Report) last released its earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a net margin of 9.85% and a return on equity of 18.69%. On average, research analysts predict that Amdocs will post 6.19 EPS for the current fiscal year.
Amdocs Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Tuesday, December 31st were issued a $0.479 dividend. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $1.92 annualized dividend and a yield of 2.21%. Amdocs’s payout ratio is 45.28%.
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
- Five stocks we like better than Amdocs
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- The How And Why of Investing in Oil Stocks
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.